one more breath…
Information
Information
Information
What’s New
Read about the treatment experiences of other pancreatic cancer patients, including what worked, the doctors or facilities they worked with, and more. Then share your story HERE.
Learn more about cutting-edge research in pancreatic cancer and gain insights from the scientists who are advancing new treatment options.
Read about the different drugs, new approaches, and latest developments in cutting-edge science being tested in active trials that are available to pancreatic cancer patients.
Educate yourself about pancreatic cancer and learn ways to make your life more comfortable during and after treatment. Find information on nutrition, exercise, and more to help you navigate life with pancreatic cancer.
Follow our up-to-the-minute newsfeed of the latest medical and scientific journal articles and abstracts related to pancreatic cancer.
Findings from the ACCORD and MPACT study established FOLFIRINOX and the combination of gemcitabine and nab-paclitaxel (Abraxane) as frontline standards of care in metastatic pancreatic cancer, respectively. However, apart from the alterative dosing and scheduling strategies that had been evaluated,…
Stay Connected
Join the conversation on our digital communities.
In an interview, Rob Greenstein discussed the role Let’s Win played for his family. Says Greenstein, “Pancreatic cancer that is diagnosed earlier is more treatable, so there is research focused on earlier detection, through blood tests, or monitoring of people…
Are you a health care professional who wants to know more about the risks, symptoms, and treatments for pancreatic cancer? Join our webinars to learn more!
Peter De Rosa of Pancreatic Cancer UK provides an update on how the COVID-19 pandemic has impacted pancreatic cancer patients in the UK.
An affiliate of
In partnership with
